The potential targets in immunotherapy of atherosclerosis-Reference-Cited by-同舟云学术

The potential targets in immunotherapy of atherosclerosis

Published:2021-11-14 Issue: Volume: Page:1-18
ISSN:0883-0185
Container-title:International Reviews of Immunology
language:en
Short-container-title:International Reviews of Immunology

Author:

Aghamajidi Azin¹²,Gorgani Melika¹²³,Shahba Faezeh¹²,Shafaghat Zahra¹²,Mojtabavi Nazanin¹²

Affiliation:

1. Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

2. Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran

3. Immunology Board for Transplantation and Cell-Based Therapeutics (ImmunoTACT), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08830185.2021.1988591

Reference194 articles.

Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?

2. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

3. Mechanisms of Disease: Toll-like receptors in cardiovascular disease

4. Targeting inflammation in atherosclerosis — from experimental insights to the clinic

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism Serves as a Bridge Between Cardiomyocytes and Immune Cells in Cardiovascular Diseases;Cardiovascular Drugs and Therapy;2024-01-18

2. The LyP-1 cyclic peptide modified mesoporous polydopamine nanospheres for targeted delivery of triptolide regulate the macrophage repolarization in atherosclerosis;Nanotechnology Reviews;2024-01-01

3. Digital transformation of the wood construction supply chain through building information modelling: current state of practice;Construction Innovation;2023-12-01

4. New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis;Frontiers in Pharmacology;2022-04-21